Competence Center Skintegral, Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany.
Am J Clin Dermatol. 2010;11(4):247-67. doi: 10.2165/11533220-000000000-00000.
Botanical extracts and single compounds are increasingly used in cosmetics but also in over-the-counter drugs and food supplements. The focus of the present review is on controlled clinical trials with botanicals in the treatment of acne, inflammatory skin diseases, skin infections, UV-induced skin damage, skin cancer, alopecia, vitiligo, and wounds. Studies with botanical cosmetics and drugs are discussed, as well as studies with botanical food supplements. Experimental research on botanicals was considered to a limited extent when it seemed promising for clinical use in the near future. In acne therapy, Mahonia, tea tree oil, and Saccharomyces may have the potential to become standard treatments. Mahonia, Hypericum, Glycyrrhiza and some traditional Chinese medicines appear promising for atopic dermatitis. Some plant-derived substances like dithranol and methoxsalen (8-methoxypsoralen) [in combination with UVA] are already accepted as standard treatments in psoriasis; Mahonia and Capsicum (capsaicin) are the next candidates suggested by present evidence. Oral administration and topical application of antioxidant plant extracts (green and black tea, carotenoids, coffee, and many flavonoids from fruits and vegetables) can protect skin from UV-induced erythema, early aging, and irradiation-induced cancer. Hair loss and vitiligo are also traditional fields of application for botanicals. According to the number and quality of clinical trials with botanicals, the best evidence exists for the treatment of inflammatory skin diseases, i.e. atopic dermatitis and psoriasis. However, many more controlled clinical studies are needed to determine the efficacy and risks of plant-derived products in dermatology. Safety aspects, especially related to sensitization and photodermatitis, have to be taken into account. Therefore, clinicians should not only be informed of the beneficial effects but also the specific adverse effects of botanicals used for dermatologic disorders and cosmetic purposes.
植物提取物和单一化合物越来越多地被用于化妆品,也被用于非处方药物和食品补充剂。本综述的重点是关于植物在治疗痤疮、炎症性皮肤病、皮肤感染、紫外线引起的皮肤损伤、皮肤癌、脱发、白癜风和伤口方面的对照临床试验。讨论了具有植物性化妆品和药物的研究,以及具有植物性食品补充剂的研究。当植物在不久的将来具有临床应用的潜力时,才会在一定程度上考虑对其进行实验研究。在痤疮治疗中,马霍尼娅、茶树油和酿酒酵母可能具有成为标准治疗方法的潜力。马霍尼娅、贯叶连翘、甘草和一些中药对特应性皮炎有希望。一些植物来源的物质,如地蒽酚和补骨脂素(8-甲氧基补骨脂素)[与 UVA 联合使用],已经被接受为银屑病的标准治疗方法;马霍尼娅和辣椒(辣椒素)是目前证据表明的下一个候选药物。口服和局部应用抗氧化植物提取物(绿茶、红茶、类胡萝卜素、咖啡和许多来自水果和蔬菜的类黄酮)可以保护皮肤免受紫外线引起的红斑、早期衰老和辐射引起的癌症。脱发和白癜风也是植物应用的传统领域。根据对照临床试验的数量和质量,植物在治疗炎症性皮肤病方面,即特应性皮炎和银屑病,具有最佳的证据。然而,还需要进行更多的对照临床试验,以确定植物源性产品在皮肤科中的疗效和风险。安全性方面,特别是与致敏和光皮炎有关的安全性,必须加以考虑。因此,临床医生不仅应该了解有益的效果,还应该了解用于治疗皮肤疾病和美容目的的植物的特定不良反应。